Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography. 1981

W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff

We describe a sensitive high pressure liquid chromatographic (HPLC) procedure for the analysis of the new beta-lactam antibiotic moxalactam. Conditions are described for either measurement of total drug concentration or the concentration of the individual isomers. The proteins in a 1.0 ml plasma sample are denatured with isopropyl alcohol which is then extracted into a chloroform reagent, leaving the drug in the aqueous phase. An aliquot is then injected into a mu-bondapak phenyl column. A similar extraction procedure was employed for tissue homogenates. Linear regression analysis and comparison of the HPLC assay with the microbiological assay gave a correlation coefficient of 0.97. Analysis of tissue samples indicated that significant concentrations of moxalactam were obtained at the site of infection.

UI MeSH Term Description Entries
D009070 Moxalactam Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. 1-Oxacephalosporin,6059-S,Disodium Latamoxef,Disodium Moxalactam,Festamoxin,Lamoxactam,Latamoxef,Lilly 127935,Ly-127935,Ly127935,Moxalactam Disodium,S-6059,Shiomarin,1 Oxacephalosporin,6059 S,6059S,Disodium, Moxalactam,Latamoxef, Disodium,Ly 127935,Moxalactam, Disodium,S 6059,S6059
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
April 1979, American journal of clinical pathology,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
January 2011, Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
May 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
November 1981, The Journal of clinical endocrinology and metabolism,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
January 1999, Methods in molecular medicine,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
April 1978, Archives of disease in childhood,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
January 1993, The American journal of the medical sciences,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
December 1977, Thrombosis and haemostasis,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
March 1982, Journal of chromatography,
W F Diven, and B D Obermeyer, and R L Wolen, and V L Yu, and J Lyon, and J Zuravleff
March 1998, Journal of chromatography. B, Biomedical sciences and applications,
Copied contents to your clipboard!